Neuland Laboratories Ltd

NEULANDLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,324 cr, stock is ranked 884
Moderate RiskStock is 2.97x as volatile as Nifty
1,019.8012.40 (-1.20%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,324 cr, stock is ranked 884
Moderate RiskStock is 2.97x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
20.75
PB RatioPB Ratio
1.68
Dividend YieldDiv. Yield
0.48%
Sector PESector PE
32.05
Sector PBSector PB
4.77
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

67%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

Investor PresentationView older 

May 10, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022670.32766.60953.01953.1516.4416.2180.6363.81
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnMay 11, 2022

Neuland Laboratories Limited has informed the Exchange about Newspaper Advertisements | Download

Neuland Laboratories Limited has informed the Exchange about Newspaper Advertisements | Download

Investor Presentation 
Announced OnMay 10, 2022

Neuland Laboratories Limited has informed the Exchange about Investor Presentation | Download

Neuland Laboratories Limited has informed the Exchange about Investor Presentation | Download

Cash Dividend 
Ex. DateJun 29, 2021

Final • Div/Share: ₹ 3

See all events